Advertisement

Effects of Hemoglobin in Sepsis

  • S. R. Fischer
  • H. G. Bone
  • D. L. Traber
Conference paper
  • 100 Downloads
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1997)

Abstract

Sepsis remains a major contributor to morbidity and mortality among the patient population of intensive care units [1]. Despite extensive research, treatment remains symptomatic and supportive. Clinically, sepsis in its hyperdynamic state is characterized by hypotension due to decreased systemic vascular resistance. The cardiac output is elevated in most cases of clinical sepsis. The vascular system is unresponsive to endogenous and exogenous catecholamines, myocardial contractility is decreased, and there is increased precapillary shunting manifesting itself as an increase in central venous oxygen saturation. As the syndrome worsens, a hypo-dynamic state follows, with circulatory shock and lactic acidosis secondary to tissue hypoxia, often leading to multiple organ dysfunction syndrome (MODS) and death.

Keywords

Nitric Oxide Mean Arterial Pressure Renal Blood Flow Multiple Organ Dysfunction Syndrome Regional Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonymous (1990) Increase in National Hospital Discharge Survey rates for septicemia–United States, 1979–1987. MMWR–Morbidity Mortality Weekly Report 39: 31–34Google Scholar
  2. 2.
    Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376PubMedCrossRefGoogle Scholar
  3. 3.
    Furchgott RF (1988) Studies on relaxation of rabbit aorta by sodium nitrite: Basis for the proposal that the acid-activatable component of the inhibitory factor from retractor penis is inorganic nitrate and the endothelium-derived relaxing factor is nitric oxide. In: Van Houtte PM (ed) Mechanism of vasodilatation. Raven Press, New York, pp 401–414Google Scholar
  4. 4.
    Craven PA, DeRubertis FR (1978) Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. J Biol Chem 253: 8433–8443PubMedGoogle Scholar
  5. 5.
    Evans T, Carpenter A, Kinderman H, Cohen J (1993) Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41: 77–81PubMedGoogle Scholar
  6. 6.
    Barthlen W, Stadler J, Lehn NL, Miethke T, Bartels H, Siewert JR (1994) Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor alpha and negatively with body temperature in patients with postoperative abdominal sepsis. Shock 2: 398–401PubMedCrossRefGoogle Scholar
  7. 7.
    Fronticelli C, Karavitis M (1994) Reaction of nitric oxide with hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 22: A99 (Abst)Google Scholar
  8. 8.
    Sharma VS, John ME, Waterman MR (1982) Functional studies on hemoglobin opossum. Conclusions drawn regarding the role of the distal histidine. J Biol Chem 257: 11887–11892PubMedGoogle Scholar
  9. 9.
    Jia L, Bonaventura C, Bonaventura J, Stamler JS (1996) S-nitrosohaemoglobin–a dynamic activity of blood involved in vascular control. Nature 380: 221–226PubMedCrossRefGoogle Scholar
  10. 10.
    Rioux F, Petitclerc E, Audet R, Drapeau G, Fielding RM, Marceau F (1994) Recombinant human hemoglobin inhibits both constitutive and cytokine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings. J Cardiovasc Pharmacol 24: 229–237PubMedGoogle Scholar
  11. 11.
    Freas W, Llave R, Sing M, Hart J, McQuillan P, Muldoon S (1995) Contractile effects of diaspirin cross-linked hemoglobin (DCLHb) on isolated porcine blood vessels. J Lab Clin Med 125: 762–767PubMedGoogle Scholar
  12. 12.
    Sharma AC, Gulati A (1994) Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J Lab Clin Med 123: 299–308PubMedGoogle Scholar
  13. 13.
    Katsuyama SS, Cole DJ, Drummond JC, Bradley K (1994) Nitric oxide mediates the hypertensive response to a modified hemoglobin solution (DCLHb) in rats. Artif Cells Blood Substit Immobil Biotechnol 22: 1–7PubMedCrossRefGoogle Scholar
  14. 14.
    Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS (1993) A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122: 301–308PubMedGoogle Scholar
  15. 15.
    Malcolm DS, Hamilton IN Jr, Schultz SC, Cole F, Burhop K (1994) Characterization of the hemodynamic response to intravenous diaspirin cross-linked hemoglobin solution in rats. Artif Cells Blood Substit Immobil Biotechnol 22: 91–107PubMedCrossRefGoogle Scholar
  16. 16.
    Kida Y, Iwata S, Gyoutoku Y, Aikou A, Yamakawa T, Nishi K (1991) Vascular responsiveness to various vasoactive substances after exchange transfusion with pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) solution in anesthetized rats. Artif Organs 15: 5–14PubMedCrossRefGoogle Scholar
  17. 17.
    Hess JR, Macdonald VW, Brinkley WW (1993) Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 74: 1769–1778PubMedGoogle Scholar
  18. 18.
    Macdonald VW, Motterlini R (1994) Vasoconstrictor effects in isolated rabbit heart perfused with bis(3,5-dibromosalicyl)fumarate cross-linked hemoglobin (alpha alpha Hb). Artif Cells Blood Substit Immobil Biotechnol 22: 565–575PubMedCrossRefGoogle Scholar
  19. 19.
    Biessels PT, Hak JB, Sleeker WK, van Beek JH, Bakker JC (1992) Effects of modified hemoglobin solutions on the isolated rabbit heart. Biomateri Artif Cells Immobil Biotechnol 20: 693–696Google Scholar
  20. 20.
    Yamakawa T, Miyauchi Y, Nishi K (1990) Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and stroma-free hemoglobin on cardiac function in isolated rat heart. Artif Organs 14: 208–217PubMedCrossRefGoogle Scholar
  21. 21.
    Looker D, Abbott-Brown D, Cozart P, et al (1992) A human recombinant haemoglobin designed for use as a blood substitute. Nature 356: 258–260PubMedCrossRefGoogle Scholar
  22. 22.
    Fedorov NA, Iarochkin VS, Koziner VB, Khachaturian AA, Rozenberg GI (1978) Support of respiration and hemodynamics by complete blood replacement with artificial oxygen carriers: Polyhemoglobinalbumin and polyhemoglobin. Doklady Akademii Nauk SSSR 243: 1324–1326PubMedGoogle Scholar
  23. 23.
    Chatterjee R, Welty EV, Walder RY, Pruitt SL, Rogers PH, Arnone A (1986) Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1-lysine 99 alpha 2). J Biol Chem 261: 9929–9937PubMedGoogle Scholar
  24. 24.
    DeVenuto F (1983) Modified hemoglobin solution as a resuscitation fluid. Vox Sang 44: 129–142PubMedCrossRefGoogle Scholar
  25. 25.
    Yabuki A, Yamaji K, Ohki H, Iwashita Y (1990) Characterization of a pyridoxalated hemoglobinpolyoxyethylene conjugate as a physiologic oxygen carrier. Transfusion 30: 516–520PubMedCrossRefGoogle Scholar
  26. 26.
    Malchesky PS, Takahashi T, Iwasaki K, Harasaki H, Nose Y (1990) Conjugated human hemoglobin as a physiological oxygen carrier–pyridoxalated hemoglobin polyoxyethylene conjugate (PHP). Artif Organs 13: 442–450Google Scholar
  27. 27.
    Kilbourn RG, Belloni P (1990) Endothelial coll production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 82: 772–776PubMedCrossRefGoogle Scholar
  28. 28.
    Bone HG, Schenarts PJ, Booke M, et al (1997) Pyridoxalated hemoglobin polyoxethylene conjugate normalizes the hyperdynamic circulation in septic sheep. Crit Care Med (In press)Google Scholar
  29. 29.
    Aranow JS, Wang H, Zhuang J, Fink MP (1996) Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock. Crit Care Med 24: 807–814PubMedCrossRefGoogle Scholar
  30. 30.
    Sugi K, Newald J, Traber LD, et al (1991) Cardiac dysfunction after acute endotoxin administration in conscious sheep. Am J Physiol 260: H1474 - H1481PubMedGoogle Scholar
  31. 31.
    Noshima S, Noda H, Herndon DN, Traber LD, Traber DL (1993) Left ventricular performance during continuous endotoxin-induced hyperdynamic endotoxemia in sheep. J Appl Physiol 74: 1528–1533PubMedGoogle Scholar
  32. 32.
    Brady AJ, Poole Wilson PA, Harding SE, Warren JB (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263: H1963 - H1966PubMedGoogle Scholar
  33. 33.
    Schulz R, Nava E, Moncada S (1992) Induction and potential biological relevance of a Ca(2 +)independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575–580PubMedCrossRefGoogle Scholar
  34. 34.
    Barriere SL, Lowry SF (1995) An overview of mortality risk prediction in sepsis. Crit Care Med 23: 376–393PubMedCrossRefGoogle Scholar
  35. 35.
    Booke M, Hinder F, McGuire R, Traber LD, Traber DL (1996) Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit Care Med 24: 835–844PubMedCrossRefGoogle Scholar
  36. 36.
    Chernow B, Rainey TG, Lake CR (1982) Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 10: 409–416PubMedCrossRefGoogle Scholar
  37. 37.
    Chernow B, Roth BL (1986) Pharmacologic manipulation of the peripheral vasculature in shock: Clinical and experimental approaches. Circ Shock 18: 141–155PubMedGoogle Scholar
  38. 38.
    Nelson S, Stewart RH, Traber L, Traber D (1991) Endotoxin-induced alterations in contractility of isolated blood vessels from sheep. Am J Physiol 260: H1790 - H1794PubMedGoogle Scholar
  39. 39.
    Landin L, Lorente JA, Renes E, Canas P, Jorge P, Liste D (1994) Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest 106: 250–256PubMedCrossRefGoogle Scholar
  40. 40.
    Hwang TL, Lau YT, Huang SF, Chen MF, Liu MS (1994) Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology 20: 638–642PubMedCrossRefGoogle Scholar
  41. 41.
    Jones SB, Romano FD (1990) Myocardial beta adrenergic receptor coupling to adenylate cyclase during developing septic shock. Circ Shock 30: 51–61PubMedGoogle Scholar
  42. 42.
    Carcillo JA, Litten RZ, Roth BL (1989) Norepinephrine-induced phosphorylation of a 25 kD phosphoprotein in rat aorta is altered in intraperitoneal sepsis. Circ Shock 28: 257–265PubMedGoogle Scholar
  43. 43.
    Kilbourn RG, Joly G, Cashon B, DeAngelo J, Bonaventura J (1994) Cell-free hemoglobin reverses the endotoxin-mediated hyporesponsivity of rat aortic rings to alpha-adrenergic agents. Biochem Biophys Res Comm 199: 155–162PubMedCrossRefGoogle Scholar
  44. 44.
    Bone HG, Schenarts PJ, Fischer SR, McGuire R, Traber LD, Traber DL (1997) Pyridoxalated hemoglobin polyoxyethylene conjugate reverses hyperdynamic circulation in septic sheep without effecting regional perfusion or organ function. Am J Physiol (In’press)Google Scholar
  45. 45.
    Cocks TM, Malta E, King SJ, Woods RL, Angus JA (1991) Oxyhatmoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 196: 177–182PubMedCrossRefGoogle Scholar
  46. 46.
    Theissen JL, Loick HM, Curry BB, Traber LD, Herndon DN, Traber DL (1991) Time course of hypoxic pulmonary vasoconstriction after endotoxin infusion in unanesthetized sheep. J Appl Physiol 70: 2120–2125PubMedGoogle Scholar
  47. 47.
    Nelson DP, Samsel RW, Wood LD, Schumacker PT (1988) Pathological supply dependence of systemic and intestinal OZ uptake during endotoxemia. J Appl Physiol 64: 2410–2419PubMedGoogle Scholar
  48. 48.
    Bersten A, Sibbald WJ (1989) Circulatory disturbances in multiple systems organ failure. Crit Care Clin 5: 233–254PubMedGoogle Scholar
  49. 49.
    Faraci FM, Brian JE Jr (1994) Nitric oxide and the cerebral circulation. Stroke 25: 692–703PubMedCrossRefGoogle Scholar
  50. 50.
    Pelligrino DA, Koenig HM, Albrecht RF (1993) Nitric oxide synthesis and regional cerebral blood flow responses to hypercapnia and hypoxia in the rat. J Cereb Blood Flow Metab 13: 80–87PubMedCrossRefGoogle Scholar
  51. 51.
    Meyer J, Hinder F, Stothert J Jr, Traber LD, Herndon DN, Flynn JT (1994) Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J Appl Physiol 76: 2785–2793PubMedGoogle Scholar
  52. 52.
    Faraci FM (1991) Role of endothelium-derived relaxing factor in cerebral circulation: Large arteries vs. microcirculation. Am J Physiol 261: H1038 - H1042PubMedGoogle Scholar
  53. 53.
    Booke M, Hinder F, McGuire R, Traber LD, Traber DL (1995) Cerebral perfusion in ovine sepsis treated with nitric oxide inhibition versus catecholamine. Anesth Analg 80: S50 (Abst)Google Scholar
  54. 54.
    Ueno M, Lee TJ (1993) Endotoxin decreases the contractile responses of the porcine basilar artery to vasoactive substances. J Cereb Blood Flow Metab 13: 712–719PubMedCrossRefGoogle Scholar
  55. 55.
    Fish RE, Lang CH, Spitzer JA (1986) Regional blood flow during continuous low-dose endotoxin infusion. Circ Shock 18: 267–275PubMedGoogle Scholar
  56. 56.
    Raper RF, Sibbald WJ, Hobson J, Rutledge FS (1991) Effect of PGE1 on altered distribution of regional blood flows in hyperdynamic sepsis. Chest 100: 1703–1711PubMedCrossRefGoogle Scholar
  57. 57.
    Ferguson JL, Spitzer JJ, Miller HI (1978) Effects of endotoxin on regional blood flow in the un-anesthetized guinea pig. J Surg Res 25: 236–243PubMedCrossRefGoogle Scholar
  58. 58.
    Lang CH, Bagby GJ, Ferguson JL, Spitzer JJ (1984) Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol 246: R331 - R337PubMedGoogle Scholar
  59. 59.
    Mourelatos MG, Enzer N, Ferguson JL, Rypins EB, Burhop KE, Law WR (1996) The effects of di-aspirin cross-linked hemoglobin in sepsis. Shock 5: 141–148PubMedCrossRefGoogle Scholar
  60. 60.
    Walker JF, Cumming AD, Lindsay RM, Solez K, Linton AL (1986) The renal response produced by nonhypotensive sepsis in a large animal model. Am J Kid Dis 8: 88–97PubMedGoogle Scholar
  61. 61.
    Lübbesmeyer HJ, Woodson L, Traber LD, Flynn JT, Herndon DN, Traber DL (1988) Immunoreactive atrial natriuretic factor is increased in ovine model of endotoxemia. Am J Physiol 254: R567 - R571PubMedGoogle Scholar
  62. 62.
    Redl G, Woodson L, Traber LD, et al (1992) Mechanism of immunoreactive atrial natriuretic factor release in an ovine model of endotoxemia. Circ Shock 38: 34–41PubMedGoogle Scholar
  63. 63.
    Hinder F, Booke M, Traber LD, et al (1996) Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit Care Med 24: 131–136PubMedCrossRefGoogle Scholar
  64. 64.
    Lingnau W, McGuire R, Dehring DJ, et al (1996) Changes in regional hemodynamics after nitric oxide inhibition during ovine bacteremia. Am J Physiol 270: R207 - R216PubMedGoogle Scholar
  65. 65.
    Booke M, Hinder F, McGuire R, Traber LD, Traber DL (1996) Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: Effects on regional blood flow. Shock 5: 362–370PubMedCrossRefGoogle Scholar
  66. 66.
    Martin CM, Sibbald WJ (1994) Modulation of hemodynamics and organ blood flow by nitric oxide synthase inhibition is not altered in normotensive, septic rats. Am J Respir Crit Care Med 150: 1539–1544PubMedGoogle Scholar
  67. 67.
    Badr KF, Kelley VE, Rennke HG, Brenner BM (1986) Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int 30: 474–480PubMedCrossRefGoogle Scholar
  68. 68.
    Tempel GE, Cook JA, Wise WC, Halushka PV, Corral D (1986) Improvement in organ blood flow by inhibition of thromboxane synthetase during experimental endotoxic shock in the rat. J Cardiovasc Pharmacol 8: 514–519PubMedCrossRefGoogle Scholar
  69. 69.
    Nicolson AG, Haites NE, McKay NG, Wilson HM, MacLeod AM, Benjamin N (1993) Induction of nitric oxide synthase in human mesangial cells. Biochem Biophys Res Commun 193: 1269–1274PubMedCrossRefGoogle Scholar
  70. 70.
    Shultz PJ, Tayeh MA, Marletta MA, Raij L (1991) Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J Physiol 261: F600 - F606PubMedGoogle Scholar
  71. 71.
    Kvietys PR, McLendon JM, Bulkley GB, Perry MA, Granger DN (1982) Pancreatic circulation: intrinsic regulation. Am J Physiol 242: G596 - G602PubMedGoogle Scholar
  72. 72.
    Breslow MJ, Miller CF, Parker SD, Walman AT, Traystman RJ (1987) Effect of vasopressors on organ blood flow during endotoxin shock in pigs. Am J Physiol 252: H291 - H300PubMedGoogle Scholar
  73. 73.
    Hersch M, Gnidec AA, Bersten AD, Troster M, Rutledge FS, Sibbald WJ (1990) Histologic and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 107: 397–410PubMedGoogle Scholar
  74. 74.
    Meyer J, Hinder F, Stothert J, et al (1994) Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J Appl Physiol 76: 2785–2793PubMedGoogle Scholar
  75. 75.
    Eldridge J, Russell R, Christenson R, et al (1996) Liver function and morphology after resuscitation from severe hemorrhage shock with hemoglobin solutions or autologous blood. Grit Care Med 24: 663–671CrossRefGoogle Scholar
  76. 76.
    Crowley JP, Metzger J, Gray A, Pivacek LE, Cassidy G, Valeri CR (1993) Infusion of stroma-free cross-linked hemoglobin during acute Gram-negative bacteremia. Circ Shock 41: 144–149PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • S. R. Fischer
  • H. G. Bone
  • D. L. Traber

There are no affiliations available

Personalised recommendations